LLY Covered Call Strategy
LLY (Eli Lilly and Company), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NYSE.
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500). Furthermore, Eli Lilly provides specialized treatments for type 2 diabetes, such as Jardiance, Trajenta, and Trulicity. In oncology, Eli Lilly offers a robust portfolio targeting various cancers. These include Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza, indicated for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal and various head and neck cancers; Retevmo, used in metastatic NSCLC, medullary thyroid, and other thyroid cancers; Tyvyt for relapsed or refractory classic Hodgkin's lymphoma and non-squamous NSCLC; and Verzenio, prescribed for HR+, HER2- metastatic breast cancer, node-positive, and early breast cancer.
LLY (Eli Lilly and Company) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $1.15T, a trailing P/E of 40.78, a beta of 0.51 versus the broader market, a 52-week range of 644.5-1249.45, average daily share volume of 3.1M, a public-listing history dating back to 1972, approximately 50K full-time employees. These structural characteristics shape how LLY stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.51 indicates LLY has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 40.78 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple. LLY pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a covered call on LLY?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
LLY snapshot
As of August 14, 2026, spot at $1,178.20, ATM IV 28.57%, IV rank 13.44%, expected move 8.19%. The covered call on LLY below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this covered call structure on LLY specifically: LLY IV at 28.57% is on the cheap side of its 1-year range, which means a premium-selling LLY covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 8.19% (roughly $96.50 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated LLY expiries trade a higher absolute premium for lower per-day decay. Position sizing on LLY should anchor to the underlying notional of $1,178.20 per share and to the trader's directional view on LLY stock.
LLY covered call setup
The LLY covered call below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With LLY at $1,178.20 on that close, the first option leg uses a $1,235.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed LLY chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 LLY shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $1,178.20 | long |
| Sell 1 | Call | $1,235.00 | $19.63 |
LLY covered call risk and reward
- Net Premium / Debit
- -$115,857.50
- Max Profit (per contract)
- $7,642.50
- Max Loss (per contract)
- -$115,856.50
- Breakeven(s)
- $1,158.58
- Risk / Reward Ratio
- 0.066
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
LLY covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on LLY. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$115,856.50 |
| $260.52 | -77.9% | -$89,805.96 |
| $521.02 | -55.8% | -$63,755.41 |
| $781.53 | -33.7% | -$37,704.87 |
| $1,042.03 | -11.6% | -$11,654.33 |
| $1,302.54 | +10.6% | +$7,642.50 |
| $1,563.04 | +32.7% | +$7,642.50 |
| $1,823.55 | +54.8% | +$7,642.50 |
| $2,084.05 | +76.9% | +$7,642.50 |
| $2,344.56 | +99.0% | +$7,642.50 |
When traders use covered call on LLY
Covered calls on LLY are an income strategy run on existing LLY stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
LLY thesis for this covered call
The market-implied 1-standard-deviation range for LLY extends from approximately $1,081.70 on the downside to $1,274.70 on the upside. A LLY covered call collects premium on an existing long LLY position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether LLY will breach that level within the expiration window. Current LLY IV rank near 13.44% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on LLY at 28.57%. As a Healthcare name, LLY options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to LLY-specific events.
LLY covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. LLY positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move LLY alongside the broader basket even when LLY-specific fundamentals are unchanged. Short-premium structures like a covered call on LLY carry tail risk when realized volatility exceeds the implied move; review historical LLY earnings reactions and macro stress periods before sizing. Always rebuild the position from current LLY chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on LLY?
- A covered call on LLY is the covered call strategy applied to LLY (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With LLY stock at $1,178.20 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed LLY chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are LLY covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the LLY covered call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 28.57%), the computed maximum profit is $7,642.50 per contract and the computed maximum loss is -$115,856.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a LLY covered call?
- The breakeven for the LLY covered call priced on this page is roughly $1,158.58 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The LLY market-implied 1-standard-deviation expected move in the same options snapshot is approximately 8.19%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on LLY?
- Covered calls on LLY are an income strategy run on existing LLY stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current LLY implied volatility affect this covered call?
- LLY ATM IV is at 28.57% with IV rank near 13.44%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.